Aggarwal Aakash, Manrai Manish, Kochhar Rakesh
Aakash Aggarwal, Department of Internal Medicine, SUNY Upstate, Syracuse, NY 13210, United States.
World J Gastroenterol. 2014 Dec 28;20(48):18092-103. doi: 10.3748/wjg.v20.i48.18092.
Acute pancreatitis remains a clinical challenge, despite an exponential increase in our knowledge of its complex pathophysiological changes. Early fluid therapy is the cornerstone of treatment and is universally recommended; however, there is a lack of consensus regarding the type, rate, amount and end points of fluid replacement. Further confusion is added with the newer studies reporting better results with controlled fluid therapy. This review focuses on the pathophysiology of fluid depletion in acute pancreatitis, as well as the rationale for fluid replacement, the type, optimal amount, rate of infusion and monitoring of such patients. The basic goal of fluid epletion should be to prevent or minimize the systemic response to inflammatory markers. For this review, various studies and reviews were critically evaluated, along with authors' recommendations, for predicted severe or severe pancreatitis based on the available evidence.
尽管我们对急性胰腺炎复杂的病理生理变化的认识呈指数级增长,但它仍然是一个临床挑战。早期液体治疗是治疗的基石,并且被普遍推荐;然而,在补液的类型、速度、量和终点方面缺乏共识。最新研究报告称控制性液体治疗有更好的效果,这进一步加剧了混乱。本综述聚焦于急性胰腺炎中液体消耗的病理生理学,以及补液的原理、此类患者的补液类型、最佳量、输注速度和监测。液体补充的基本目标应该是预防或尽量减少对炎症标志物的全身反应。在本综述中,根据现有证据,对各种研究和综述以及作者针对预测为重症或重症胰腺炎的建议进行了严格评估。